Investigation Underway on SPTN, BGSF, COOP, and EPIX Mergers by Class Action Law Firm

Class Action Firm Investigates Major Mergers



In a notable development, Monteverde & Associates PC, a renowned class action law firm based in New York, is conducting an inquiry into several crucial mergers affecting shareholders of specific companies. The firm, celebrated for recovering millions for shareholders, is spearheaded by attorney Juan Monteverde, who has distinguished himself as a leading figure in the field. The firm has also been recognized in the 2024 ISS Securities Class Action Services Report as a Top 50 Firm.

The first case involves the proposed sale of SpartanNash Company (NASDAQ: SPTN). Shareholders are set to receive $26.90 per share in cash from CS Wholesale Grocers. Unfortunately, this raise concerns regarding the fairness and adequacy of the compensation offered to shareholders. The crucial shareholder vote is scheduled for September 9, 2025. Affected individuals are strongly encouraged to participate and voice their opinions regarding the transaction's terms.

BGSF, Inc.



Another case under scrutiny is the acquisition of BGSF, Inc. (NYSE: BGSF). The firm's Professional Division is being sold to INSPYR Solutions for $99 million. This transaction has raised questions about its impact on BGSF shareholders, especially regarding the sale price's reflection of the division's true value. The vote for this transaction is planned for September 4, 2025.

Mr. Cooper Group Inc.



Next on the list is Mr. Cooper Group Inc. (NASDAQ: COOP). This company is proposing a merger with Rocket Companies, where shareholders will receive a fixed exchange ratio of 11 Rocket shares for each share of Mr. Cooper common stock. This merger means that Mr. Cooper shareholders would control about 25% of the combined entity, raising several questions about potential ramifications that could unfold following the merger. The vote is scheduled for September 3, 2025.

ESSA Pharma Inc.



The firm is also looking into the merger involving ESSA Pharma Inc. (NASDAQ: EPIX), which intends to merge with Xeno Acquisition Corp. Under the proposed terms, ESSA shareholders are expected to receive cash payments determined by the company's cash balance at closing, minus transaction-related costs. The merger also includes contingent value rights that could yield additional payments based on company performance after the completion of the transaction. Shareholders are encouraged to learn more about this case, which can be found in detail on Monteverde’s website.

Next Steps for Shareholders



In response to these ongoing investigations, Monteverde & Associates urges affected shareholders to act quickly and participate in the voting processes associated with these mergers. They emphasize that it is free to become involved and that those with further inquiries can visit the firm's website or reach out via email or phone at the provided contact details.

About Monteverde & Associates PC



Established in a prestigious location within the Empire State Building, Monteverde & Associates PC is a national class action securities firm. With a track record that highlights success not only in lower courts but also in appellate courts, including the U.S. Supreme Court, the firm firmly stands by its motto that no company, director, or officer is above the law. The firm remains committed to ensuring that shareholders retain their rightful interests.

For more information, journalists and affected shareholders alike are encouraged to reach out directly at [email protected] or call (212) 971-1341.

Stay informed on the latest updates from Monteverde & Associates and the ongoing investigations concerning these critical mergers affecting shareholder welfare.

Topics Financial Services & Investing)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.